Navigation Links
Yongye International to Present at Upcoming Investor Conferences
Date:5/10/2010

BEIJING, May 10 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG), ("Yongye" or the "Company") a leading developer, manufacturer, and distributor of Shengmingsu brand plant and animal nutrient products in the People's Republic of China ("PRC"), today announced that the Company's management team will present at four investment conferences in May 2010.

The date, time and location of Yongye's presentations at the upcoming investor conferences are as follows:

    Conference:   Seventh Annual Piper Jaffray China Growth Conference
    Date:         Thursday, May 13, 2010
    Time:         3:00 p.m. & 4:00 p.m.
    Venue:        Le Parker Meridien Hotel
                  119 West 56th Street
                  New York, NY 10019

    Conference:   Second Annual CCG China Rising Investment Conference
    Date:         Monday, May 17, 2010
    Time:         11:00 a.m.
    Venue:        The Broadway Room
                  Grand Hyatt New York
                  109 East 42nd Street
                  New York, NY 10017

    Conference:   Oppenheimer 4th Annual China Dragon Call Conference
    Date:         Tuesday, May 18, 2010
    Time:         3:30 p.m.
    Venue:        Executive Board Room
                  Oppenheimer & Co., Inc.
                  300 Madison Avenue
                  New York, NY 10017

    Conference:   BMO Capital Markets 2010 Agriculture, Protein & Fertilizer
                  Conference
    Date:         Wednesday, May 19, 2010
    Time:         9:30 a.m. Eastern Time
    Venue:        Ballroom V
                  Grand Hyatt New York
                  109 East 42nd Street
                  New York, NY 10017

The Company's presentation at the BMO Capital Markets 2010 Agriculture, Protein & Fertilizer Conference will be webcast live and available in archive for six months following the conference at the following URL: http://tinyurl.com/YONGPresentationatBMO

About Yongye International, Inc.

Yongye International is a Chinese organic agricultural nutrient company headquartered in Beijing, with its production facilities located in Hohhot, Inner Mongolia, China. Yongye markets two lines of organic nutrient products: a liquid nutrient product which is sprayed on plants and a powder nutrient product which is added to animal feed. Both products are sold under the brand name "Shengmingsu," which means "life essential" in Chinese. The Company's patented and patent pending formulas and proprietary extraction processes allow it to create products that increase crop yields and improve the health of livestock. The Company sells its products to provincial or regional distributors, who then channel those products to a carefully selected network of independently-owned Yongye branded stores in China. For more information, please visit the Company's website at http://www.yongyeintl.com .

    For more information, please contact:

    Yongye International, Inc.
     Mr. Larry Gilmore-VP of Corporate Strategy
     Phone: +86-10-8232-8866 x8880
     Email: larry.gilmore@yongyeintl.com

    CCG Investor Relations, Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915
     Email: crocker.coulson@ccgir.com

     Athan Dounis, Account Manager
     Phone: +1-646-213-1916
     Email: athan.dounis@ccgir.com
     Web:   http://www.ccgirasia.com


'/>"/>
SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
2. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
3. Yongye Biotechnology International Retains CCG Investor Relations
4. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
5. Yongye Biotechnology International Announces Second Quarter Results
6. Yongye Biotechnology International Raises $9.4 Million in Private Placement
7. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
8. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
9. Yongye Biotechnology Announces Record Third Quarter Results
10. Yongye Biotechnology to Present at Roth Conference
11. Yongye Biotechnology International to Expand its Network of Branded Stores
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
(Date:2/16/2017)... DENVER , Feb. 16, 2017 UCHealth ... hospital to utilize LungDirect for pulmonary nodule patient management. ... a nodule, or a spot on the lung, UCHealth ... spent on manual data entry. Stephanie ... been tracking my nodule patients with an Excel spreadsheet, ...
(Date:2/16/2017)... 16, 2017  Rhythm, a biopharmaceutical company ... that result in life-threatening metabolic disorders, today ... mezzanine round of financing with existing investors ... New Enterprise Associates, Pfizer Venture Investments, Third ... investment fund. Rhythm will use the proceeds ...
(Date:2/15/2017)... 15. Februar 2017  Trianni, Inc. („TRIANNI") gab ... (Janssen) eine Lizenzvereinbarung über die Verwendung der The ... Plattform für die Entdeckung monoklonaler Antikörper. ... chimäres Gensegmentdesign aus, das Janssen den Zugang ... bietet und das für die schelle Isolierung vollständig ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/23/2017)... , Jan. 23, 2017  The latest mobile ... smartphone prices have dropped dramatically. The quarterly average price ... 2013 to $276 in Q4 2016.  There are now ... price of $116, up from just 28 a year ... According to Maxine Most , Acuity Market ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
Breaking Biology News(10 mins):